XPOVIO® (selinexor) Approved for Commercialization in Indonesia, Further Expanding Antengene's Commercial Presence in APAC – XPOVIO® is the first and only approved XPO1 inhibitor in Indonesia.… CISION PRNewswireMarch 5, 2025
Press ReleaseNew TXOne Networks OT/ICS Cybersecurity Report Details Growing Range of Risks Facing Companies as Digital Transformation Unfolds Globally Supply-chain vulnerabilities, aging infrastructure, patching difficulties and gaps in incident response demand urgent… CISION PRNewswireMarch 5, 2025
Global Terrorism Index 2025: Terrorism Spreads as Lone Wolf Attacks Dominate the West LONDON, March 5, 2025 /PRNewswire/ — The number of countries recording a… CISION PRNewswireMarch 5, 2025
XPOVIO® (selinexor) Approved for Commercialization in Indonesia, Further Expanding Antengene's Commercial Presence in APAC – XPOVIO® is the first and only approved XPO1 inhibitor in Indonesia.… CISION PRNewswireMarch 5, 2025
Kuaishou's MSCI ESG Rating Upgraded to "A," Highlighting Outstanding Achievements in Sustainable Development HONG KONG, March 5, 2025 /PRNewswire/ — Kuaishou Technology ("Kuaishou" or the "Company";… CISION PRNewswireMarch 5, 2025
Press ReleaseInterSystems Unveils IntelliCare: A Next-Generation, AI-Powered Electronic Health Record BANGKOK, March 5, 2025 /PRNewswire/ — InterSystems, a creative data technology provider… CISION PRNewswireMarch 5, 2025
Press ReleasePantai Hospital Kuala Lumpur and IMU University Sign MoU to Advance Medical Research and Education KUALA LUMPUR, Malaysia, March 5, 2025 /PRNewswire/ — Pantai Hospital Kuala Lumpur… CISION PRNewswireMarch 5, 2025
BusinessPress ReleaseAxiom Partners with Know Your Customer to Elevate Business KYC Standards in the Digital Asset Market SINGAPORE, March 5, 2025 /PRNewswire/ — Axiom announces its partnership with Know… CISION PRNewswireMarch 5, 2025
